相关实验视频
Updated: Jun 17, 2025

23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
8.0K
内源性大麻素系统调节剂在帕金森病治疗中的治疗应用
Leonid G Khaspekov1, Sergey N Illarioshkin1
1Brain Science Institute, Research Center of Neurology, Volokolamskoye Road, 80, 125367 Moscow, Russia.
International journal of molecular sciences
|August 10, 2024
概括
内源性大麻素系统 (ECS) 在帕金森病 (PD) 发病过程中至关重要. 调节ECS为治疗PD患者的运动和非运动症状提供了一个有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子病原体的产生.
背景情况:
- 内源性大麻素系统 (ECS) 与帕金森病 (PD) 的分子病原发生有关.
- 该ECS调节内源性大麻素水平和大麻素受体 (CBRs) 的激活,影响PD的临床表现.
- 中枢神经系统中CBR的功能多样性对精确的ECS调节提出了挑战.
研究的目的:
- 在实验性PD模型和人类患者中审查ECS调节器的影响.
- 探索ECS调制对于PD治疗的治疗潜力.
- 为开发针对PD症状的新型大麻素药物提供前景.
主要方法:
- 对帕金森病中ECS调节器的现有文献进行分析.
- 包括使用体内和体外PD实验模型的研究.
- 包括来自PD患者的临床数据.
主要成果:
- 欧洲神经系统在帕金森病的分子病原发生中发挥着重要作用.
- 电脑神经系统的调节会影响PD中运动和非运动症状的发展.
- 在各种PD实验模型和PD患者中,ECS调节器已经显示出效果.
结论:
- 准内源性大麻素系统是帕金森病的一个有前途的治疗策略.
- 对ECS调节的进一步研究可能会导致PD的新药开发.
- 微调ECS调节是复杂的,但具有治疗多种PD症状的潜力.
相关概念视频
Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
172
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
172
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
207
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
207
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41

